>
Physician Claims ChatGPT Is Programmed To "Reduce Vaccine Hesitancy"
Is Something Starting To Break? Stocks Plummet And Bonds Go Nuts As Economic Data Disappoints
FDA WARNS: Deadly Virus Found in MILK, Shoppers on NOTICE | Beyond the Headlines
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
The fungus has been the subject of research to test its anti-cancer efficacy in Professor Fuad Fares' laboratory at the University of Haifa for about eight years.
It was selected as the preferred candidate for the development of a drug for pancreatic and colon cancer after showing better anti-cancer results than a variety of other fungi tested.
A few months ago, the biomedical company Cannabotech received global and exclusive rights of use for patents created in Prof. Fares' research and began leading an accelerated process of developing a botanical drug as defined by the FDA.